Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:14:51 UTC |
---|
HMDB ID | HMDB0000452 |
---|
Secondary Accession Numbers | - HMDB0000581
- HMDB0005815
- HMDB00452
- HMDB00581
- HMDB05815
|
---|
Metabolite Identification |
---|
Common Name | L-alpha-Aminobutyric acid |
---|
Description | L-alpha-Aminobutyric acid, also known as (S)-2-aminobutanoic acid, homoalanine, 2-AABA, or alpha-Aminobutyric acid, is a member of the class of compounds known as L-alpha-amino acids. L-alpha-Amino acids are alpha amino acids which have the L-configuration of the alpha-carbon atom. Amino acids are organic compounds that contain amino (-NH2) and carboxyl (-COOH) functional groups, along with a side chain (R group) specific to each amino acid. L-alpha-Aminobutyric acid is a non-proteogenic amino acid that can be found in the human kidney, in liver tissues, and in most biofluids or excreta (e.g. feces, breast milk, urine, and blood). Within the cell, L-alpha-aminobutyric acid is primarily located in the cytoplasm. alpha-Aminobutyric acid is biosynthesized by transamination of oxobutyrate, a metabolite in isoleucine biosynthesis. As a non-proteogenic amino acid, alpha-aminobutyric acid can be used by nonribosomal peptide synthases. One example of a nonribosomal peptide containing alpha-aminobutyric acid is ophthalmic acid, which was first isolated from calf lens. alpha-Aminobutyric acid is a non-essential amino acid that is primarily derived from the catabolism of methionine, threonine, and serine. High protein diets can result in significantly higher alpha-aminobutyrate levels in plasma (PMID: 26227325 ). alpha-Aminobutyric acid is elevated in the plasma of children with Reye's syndrome, tyrosinemia, homocystinuria, nonketotic hyperglycinemia, and ornithine transcarbamylase deficiency (PMID: 420125 ). alpha-Aminobutyric acid is one of the three isomers of aminobutyric acid. The two others are the neurotransmitter gamma-aminobutyric acid (GABA) and beta-aminobutyric acid (BABA) which is known for inducing plant disease resistance. |
---|
Structure | InChI=1S/C4H9NO2/c1-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(-)-2-Aminobutyric acid | ChEBI | (2S)-2-Aminobutyric acid | ChEBI | (S)-2-Aminobutanoate | ChEBI | (S)-2-Aminobutanoic acid | ChEBI | (S)-2-Aminobutyric acid | ChEBI | L-(+)-2-Aminobutyric acid | ChEBI | L-2-Aminobuttersaeure | ChEBI | L-2-Aminobutyric acid | ChEBI | L-alpha-Amino-N-butyric acid | ChEBI | L-Butyrine | ChEBI | S-Butyrine | ChEBI | (-)-2-Aminobutyrate | Generator | (2S)-2-Aminobutyrate | Generator | (S)-2-Aminobutyrate | Generator | L-(+)-2-Aminobutyrate | Generator | L-2-Aminobutyrate | Generator | L-a-Amino-N-butyrate | Generator | L-a-Amino-N-butyric acid | Generator | L-alpha-Amino-N-butyrate | Generator | L-Α-amino-N-butyrate | Generator | L-Α-amino-N-butyric acid | Generator | L-a-Aminobutyrate | Generator | L-a-Aminobutyric acid | Generator | L-alpha-Aminobutyrate | Generator | L-Α-aminobutyrate | Generator | L-Α-aminobutyric acid | Generator | (+)-2-Aminobutanoate | HMDB | (+)-2-Aminobutanoic acid | HMDB | (+)-2-Aminobutyric acid | HMDB | (+)-alpha-Aminobutyric acid | HMDB | (2S)-2-Aminobutanoate | HMDB | (2S)-2-Aminobutanoic acid | HMDB, MeSH | (S)-(+)-alpha-Aminobutyric acid | HMDB | (S)-2-amino-Butanoate | HMDB | (S)-2-amino-Butanoic acid | HMDB | 2-Aminobutanoate | HMDB | 2-Aminobutanoic acid | HMDB, MeSH | 2-Aminobutyrate | HMDB | 2S-amino-Butanoate | HMDB, Generator | 2S-amino-Butanoic acid | HMDB | alpha-Aminobutyric acid | HMDB, MeSH | L-2-amino-N-Butyric acid | HMDB | L-Ethylglycine | HMDB | Butyrine, (R)-isomer | MeSH, HMDB | 2-Aminobutyric acid | MeSH, HMDB, Generator | alpha-Aminobutyric acid, (+-)-isomer | MeSH, HMDB | Butyrine | MeSH, HMDB | Butyrine, (S)-isomer | MeSH, HMDB | L-Homoalanine | MeSH, HMDB | alpha-Aminobutyric acid, (S)-isomer | MeSH, HMDB | Homoalanine | MeSH, HMDB | alpha-Aminobutyric acid, (R)-isomer | MeSH, HMDB | Butyrine, (+-)-isomer | MeSH, HMDB | L-2-Aminobutanoate | Generator, HMDB |
|
---|
Chemical Formula | C4H9NO2 |
---|
Average Molecular Weight | 103.1198 |
---|
Monoisotopic Molecular Weight | 103.063328537 |
---|
IUPAC Name | (2S)-2-aminobutanoic acid |
---|
Traditional Name | (-)-2-aminobutyric acid |
---|
CAS Registry Number | 1492-24-6 |
---|
SMILES | CC[C@H](N)C(O)=O |
---|
InChI Identifier | InChI=1S/C4H9NO2/c1-2-3(5)4(6)7/h3H,2,5H2,1H3,(H,6,7)/t3-/m0/s1 |
---|
InChI Key | QWCKQJZIFLGMSD-VKHMYHEASA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- Fatty acid
- Amino acid
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Amine
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Primary aliphatic amine
- Organic nitrogen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | |
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.13 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 9.1008 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 6.95 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 365.2 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 537.4 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 342.8 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 59.4 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 222.2 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 60.9 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 294.3 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 242.7 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 704.7 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 600.6 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 38.2 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 669.9 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 203.9 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 274.9 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 632.6 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 464.2 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 355.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
L-alpha-Aminobutyric acid,1TMS,isomer #1 | CC[C@H](N)C(=O)O[Si](C)(C)C | 1033.7 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,1TMS,isomer #2 | CC[C@H](N[Si](C)(C)C)C(=O)O | 1141.2 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TMS,isomer #1 | CC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1185.8 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TMS,isomer #1 | CC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1198.3 | Standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TMS,isomer #1 | CC[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1318.6 | Standard polar | 33892256 | L-alpha-Aminobutyric acid,2TMS,isomer #2 | CC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1357.8 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TMS,isomer #2 | CC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1241.7 | Standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TMS,isomer #2 | CC[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1478.6 | Standard polar | 33892256 | L-alpha-Aminobutyric acid,3TMS,isomer #1 | CC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1418.9 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,3TMS,isomer #1 | CC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1319.2 | Standard non polar | 33892256 | L-alpha-Aminobutyric acid,3TMS,isomer #1 | CC[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1311.7 | Standard polar | 33892256 | L-alpha-Aminobutyric acid,1TBDMS,isomer #1 | CC[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1253.8 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,1TBDMS,isomer #2 | CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O | 1379.2 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TBDMS,isomer #1 | CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1605.1 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TBDMS,isomer #1 | CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1617.8 | Standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TBDMS,isomer #1 | CC[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1614.9 | Standard polar | 33892256 | L-alpha-Aminobutyric acid,2TBDMS,isomer #2 | CC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1780.1 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TBDMS,isomer #2 | CC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1682.0 | Standard non polar | 33892256 | L-alpha-Aminobutyric acid,2TBDMS,isomer #2 | CC[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1685.8 | Standard polar | 33892256 | L-alpha-Aminobutyric acid,3TBDMS,isomer #1 | CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2044.3 | Semi standard non polar | 33892256 | L-alpha-Aminobutyric acid,3TBDMS,isomer #1 | CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1965.0 | Standard non polar | 33892256 | L-alpha-Aminobutyric acid,3TBDMS,isomer #1 | CC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1739.9 | Standard polar | 33892256 |
|
---|
Disease References | Alzheimer's disease |
---|
- Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10. [PubMed:17031479 ]
| Kidney disease |
---|
- Chuang CK, Lin SP, Chen HH, Chen YC, Wang TJ, Shieh WH, Wu CJ: Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis. Clin Chim Acta. 2006 Feb;364(1-2):209-16. Epub 2005 Aug 8. [PubMed:16087168 ]
| Schizophrenia |
---|
- Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C: Potential metabolite markers of schizophrenia. Mol Psychiatry. 2013 Jan;18(1):67-78. doi: 10.1038/mp.2011.131. Epub 2011 Oct 25. [PubMed:22024767 ]
| Cancer with metastatic bone disease |
---|
- Tsuruta Y, Matsumoto M, Inoue H, Munemura S, Yamano S, Iguchi H: Determination of N-ethylglycine in urine of cancer patients with metastatic bone disease by HPLC using 4-(5,6-dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl chloride as a fluorescent labeling reagent. Anal Sci. 2008 Dec;24(12):1629-31. [PubMed:19075476 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
| Colorectal cancer |
---|
- Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28. [PubMed:22148915 ]
- Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14. [PubMed:25105552 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
---|
General References | - Yang W, Roth KS: Defect in alpha-ketobutyrate metabolism: a new inborn error. Clin Chim Acta. 1985 Jan 30;145(2):173-82. [PubMed:3918815 ]
- Engelborghs S, Marescau B, De Deyn PP: Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease. Neurochem Res. 2003 Aug;28(8):1145-50. [PubMed:12834252 ]
- Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA: Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem. 1984 Mar;42(3):833-7. [PubMed:6198473 ]
- Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6. [PubMed:12297216 ]
- Le Boucher J, Charret C, Coudray-Lucas C, Giboudeau J, Cynober L: Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A. Clin Chem. 1997 Aug;43(8 Pt 1):1421-8. [PubMed:9267323 ]
- Oishi M, Mochizuki Y, Sanuki E: [Regional cerebral blood flow and cerebrospinal fluid amino acid analysis in elderly dementia]. No To Shinkei. 1998 Nov;50(11):1018-21. [PubMed:9866128 ]
- Haschke-Becher E, Kainz A, Bachmann C: Reference values of amino acids and of common clinical chemistry in plasma of healthy infants aged 1 and 4 months. J Inherit Metab Dis. 2016 Jan;39(1):25-37. doi: 10.1007/s10545-015-9870-4. Epub 2015 Jul 31. [PubMed:26227325 ]
- Yudkoff M, Blazer-Yost B, Cohn R, Segal S: On the clinical significance of the plasma alpha-amino-n-butyric acid:leucine ratio. Am J Clin Nutr. 1979 Feb;32(2):282-5. [PubMed:420125 ]
|
---|